Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients

International Journal of Antimicrobial Agents

Volumn 43, Issue 6, 2014, Pages 558-562

  Sahasrabhojane, Pranoti ^a   Galloway Peña, Jessica ^a   Velazquez, Luis ^a   Saldaña, Miguel ^a   Horstmann, Nicola ^a   Tarrand, Jeffrey ^a   Shelburne, Samuel A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bacteraemia; Fluoroquinolone; Molecular epidemiology; Neutropenia; Streptococcus spp.

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CANCER PATIENT; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MULTILOCUS SEQUENCE TYPING; PRIORITY JOURNAL; SPECIES DIFFERENCE; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; COMPLICATION; DNA SEQUENCE; DRUG EFFECTS; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR TYPING; NEOPLASM; STREPTOCOCCUS; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GENES, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; NEOPLASMS; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 84902083600     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.01.031     Document Type: Article

References (15)

1. R.R. Razonable, M.R. Litzow, Y. Khaliq, K.E. Piper, M.S. Rouse, and R. Patel Bacteremia due to viridans group streptococci with diminished susceptibility to levofloxacin among neutropenic patients receiving levofloxacin prophylaxis Clin Infect Dis 34 2002 1469 1474 (Pubitemid 34553706)
2. C.J. Bishop, D.M. Aanensen, G.E. Jordan, M. Kilian, W.P. Hanage, and B.G. Spratt Assigning strains to bacterial species via the internet BMC Biol 7 2009 3
3. Y. Maeda, M. Murayama, C.E. Goldsmith, W.A. Coulter, C. Mason, and B.C. Millar et al. Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis J Antimicrob Chemother 66 2011 476 486
4. I. Rodríguez-Avial, C. Rodríguez-Avial, E. Culebras, and J.J. Picazo Fluoroquinolone resistance among invasive viridans group streptococci and Streptococcus bovis isolated in Spain Int J Antimicrob Agents 29 2007 478 480 (Pubitemid 46349597)
5. A.B. Brueggemann, S.L. Coffman, P. Rhomberg, H. Huynh, L. Almer, and A. Nilius et al. Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995 Antimicrob Agents Chemother 46 2002 680 688 (Pubitemid 34157651)
6. I. González, M. Georgiou, F. Alcaide, D. Balas, J. Liñares, and A.G. de la Campa Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci Antimicrob Agents Chemother 42 1998 2792 2798 (Pubitemid 28501205)
7. S.N. Patel, A. McGeer, R. Melano, G.J. Tyrrell, K. Green, and D.R. Pillai et al. Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada Antimicrob Agents Chemother 55 2011 3703 3708
8. R.M. Prabhu, K.E. Piper, M.R. Litzow, J.M. Steckelberg, and R. Patel Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis Eur J Clin Microbiol Infect Dis 24 2005 832 838 (Pubitemid 43042790)
9. S. Page, F. Vernel-Pauillac, O. O'Connor, S. Bremont, F. Charavay, and P. Courvalin et al. Real-time PCR detection of gyrA and parC mutations in Streptococcus pneumoniae Antimicrob Agents Chemother 52 2008 4155 4158
10. E. Pestova, J.J. Millichap, G.A. Noskin, and L.R. Peterson Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones J Antimicrob Chemother 45 2000 583 590 (Pubitemid 30255636)
11. H. Wisplinghoff, R.R. Reinert, O. Cornely, and H. Seifert Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients J Clin Microbiol 37 1999 1876 1880 (Pubitemid 29235239)
12. B.C. van Hees, M. Tersmette, R.J. Willems, B. de Jong, D. Biesma, and E.J. van Hannen Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis J Antimicrob Chemother 66 2011 1739 1744
13. D.E. Rozen, L. McGee, B.R. Levin, and K.P. Klugman Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae Antimicrob Agents Chemother 51 2007 412 416 (Pubitemid 46185254)
14. E. Varon, S. Houssaye, S. Grondin, and L. Gutmann Nonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae Antimicrob Agents Chemother 50 2006 572 579 (Pubitemid 43190968)
15. M. Ip, S.S.L. Chau, F. Chi, J.L. Tang, and P.K. Chan Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae Antimicrob Agents Chemother 51 2007 2690 2700 (Pubitemid 47206201)